Eli Lilly monoclonal antibody drug trial paused over safety concerns

Eli Lilly & Company are halting the enrollment of participants in a clinical trial of its antibody treatment for the Wuhan coronavirus (COVID-19) due to safety concerns. According to company spokeswoman Molly McCully, an independent data and safety monitoring board (DSMB) had recommended pausing enrollment in the U.S. government-sponsored trials. Lilly, however, did not say what caused the panel … Continue reading Eli Lilly monoclonal antibody drug trial paused over safety concerns

Insulin resistance happens in the gut – but how? Researchers explain

Insulin resistance is a metabolic condition often studied in relation to diabetes. This is because it is considered a precursor to Type 2 diabetes. According to a group of researchers from Canada and the U.S., obesity can bring about insulin resistance, and it all starts in the gut. Published in the journal Nature Communications, their groundbreaking finding … Continue reading Insulin resistance happens in the gut – but how? Researchers explain